ArticleThe Laryngoscope2025
Unilateral Sensorineural Hearing Loss in Children: Natural History and Clinical Characteristics.
Article in The Laryngoscope, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pediatric hearing loss in the universal newborn hearing screening era: etiologies, risk indicators, and clinical phenotypes.Frontiers in public health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveCharacterize hearing outcomes and etiologies of congenital and postnatal unilateral sensorineural hearing loss (SNHL).
methodsReviewed charts of children with unilateral SNHL, 2003-2019. Primary outcomes were changes in pure tone average (PTA) of affected and contralateral ears. Patients who failed a newborn hearing screen (NBHS) were considered 'congenital' onset, those who passed "postnatal," and those without "unknown." Demographics, infectious/genetic workup, audiograms, imaging, and hearing aid use were collected.
resultsA total of 1264 charts reviewed, 476 subjects included: 156 congenital, 252 postnatal, and 68 unknown onset. The mean (SD) of the first PTA was 53.8(29.4) dB for affected and 10.6(5.8) dB for unaffected ears. Thirty-nine percent followed up > 5 years. Change in PTA over time was 3.0(14.5) dB for affected and -1.7(7.4) dB for unaffected ears. The congenital subgroup had poorer hearing in the affected ear at the first audiogram (p < 0.0001) and was more likely to have progressive hearing loss (p = 0.0040) than the postnatal subgroup. Imaging in 296 patients revealed ipsilateral abnormalities in 26.6% of CTs and 39.6% of MRIs. Absent/hypoplastic cochlear nerve was the most common abnormal and was associated with poorer hearing than those with normal nerves (p < 0.0001). Enlarged vestibular aqueduct was not associated with progression of hearing loss.
conclusionHearing in both the affected and contralateral ears remained stable after the first audiogram in > 80% of patients. Patients with congenital loss had poorer hearing at diagnosis and were more likely to have progression than those with postnatal loss. MRI was more sensitive than CT in detecting an anatomic cause of SNHL, and absent/hypoplastic cochlear nerve was the most common finding. LEVEL OF EVIDENCE: 4:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.